1086248

Jerome Stevens Pharmaceuticals, Inc. — FEI 2431950

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bohemia, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683021 CFR 314.80(c)(2)Interval
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report